15 November 2016 - President-elect Donald Trump made the cost of prescription drugs a central part of his healthcare pitch while campaigning but has been silent on the issue since being elected.

Donald Trump and his congressional allies are making big plans to repeal the Affordable Care Act and overhaul other government health programs.

But the president-elect appears to have downgraded plans to act aggressively to control rising drug prices, handing the pharmaceutical industry an early victory and providing another illustration of the influence of lobbyists on the new Trump administration, despite Trump’s promise to “drain the swamp” of special interests in Washington.

Read Los Angeles Times article